NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Turret Capital

Turret Capital

New York City, New Yorkturretfunds.com

Overview

Turret Capital is a global biomedical investment and venture-building company that focuses on early-stage investments. Headquartered in New York with a presence in Asia, the firm's mission is to elevate global healthcare standards through company creation, investments, and cross-border strategies, particularly between the US and Asia. It identifies as a venture builder and is also classified as an accelerator/incubator, with a focus on healthcare and medical technologies.

Portfolio Companies

4

Investments

Turret Capital investments
CompanyDateStageLead
Sable BioFeb 2026SeedCo-investor
Onego BioApr 2024Series ACo-investor
Egret TherapeuticsFeb 2022SeedCo-investor
Milu LabsMar 2019SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersNew York City, New York
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.